Q3 2023 EPS Estimates for Quanterix Co. Increased by SVB Leerink (NASDAQ:QTRX)

Quanterix Co. (NASDAQ:QTRX – Get Rating) – Investment analysts at SVB Leerink upped their Q3 2023 EPS estimates for shares of Quanterix in a note issued to investors on Tuesday, May 9th. SVB Leerink analyst P. Souda now expects that the company will post earnings of ($0.34) per share for the quarter, up from their […]

Related Keywords

,Frontier Capital Management Co ,Custom Assay Development ,Nasdaq ,Invesco Ltd ,Simoa Accelerator Laboratory ,Quanterix Company Profile ,Vanguard Group Inc ,Quanterix Corp ,Blackrock Inc ,Quanterix Co ,Platinum Investment Management Ltd ,Get Rating ,Capital Management ,Investment Management ,Simoa Assay Kits ,Analysis System ,Custom Assay ,Quanterix Daily ,Quanterix ,Nasdaq Qtrx ,Qtrx ,Medical ,Earnings Estimates ,Svb Leerink Llc ,